BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26918783)

  • 1. The interaction between smoking and CYP1A1 MspI polymorphism on lung cancer: a meta-analysis in the Chinese population.
    Zhang LP; Wang CP; Li LH; Tang YF; Li WC
    Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 26918783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review.
    Zhan P; Wang Q; Qian Q; Wei SZ; Yu LK
    J Exp Clin Cancer Res; 2011 Oct; 30(1):99. PubMed ID: 22014025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of CYP1A1 MspI polymorphism in the esophageal cancer risk: a meta-analysis in the Chinese population.
    Zheng H; Zhao Y
    Eur J Med Res; 2015 Mar; 20(1):46. PubMed ID: 25886559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP1A1 MspI polymorphism is associated with prostate cancer susceptibility: evidence from a meta-analysis.
    Ding G; Xu W; Liu H; Zhang M; Huang Q; Liao Z
    Mol Biol Rep; 2013 May; 40(5):3483-91. PubMed ID: 23475304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP1A1 polymorphisms and risk of lung cancer in non-smoking Chinese women: influence of environmental tobacco smoke exposure and GSTM1/T1 genetic variation.
    Ng DP; Tan KW; Zhao B; Seow A
    Cancer Causes Control; 2005 May; 16(4):399-405. PubMed ID: 15953982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Studies of CYP1A1 Exon7 Polymorphism and -GSTM1 Interaction with Esophageal Cancer Risk: a Meta-Analysis in the Chinese Population.
    Chen XP; Xu DF; Xu WH; Ma ZC; Yao J; Fu SM
    Clin Lab; 2016 Sep; 62(9):1795-1802. PubMed ID: 28164573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of CYP1A1 MspI polymorphism with oral cancer risk in Asian populations: a meta-analysis.
    Xu JL; Xia R; Sun L; Min X; Sun ZH; Liu C; Zhang H; Zhu YM
    Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 CYP1A1 MspI polymorphism and lung cancer susceptibility.
    Xu X; Kelsey KT; Wiencke JK; Wain JC; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):687-92. PubMed ID: 8877059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of CYP1A1 polymorphisms on the risk of lung cancer: a global meta-analysis based on 71 case-control studies.
    Chen Z; Li Z; Niu X; Ye X; Yu Y; Lu S; Chen Z
    Mutagenesis; 2011 May; 26(3):437-46. PubMed ID: 21402622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does cytochrome P450 1A1 MspI polymorphism increase acute lymphoblastic leukemia risk? Evidence from 2013 cases and 2903 controls.
    Zhuo W; Zhang L; Qiu Z; Zhu B; Chen Z
    Gene; 2012 Nov; 510(1):14-21. PubMed ID: 22964275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of association studies of CYP1A1 genetic polymorphisms with digestive tract cancer susceptibility in Chinese.
    Liu C; Jiang Z; Deng QX; Zhao YN
    Asian Pac J Cancer Prev; 2014; 15(11):4689-95. PubMed ID: 24969905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between cytochrome P450 1A1 MspI polymorphism and endometrial cancer risk: a meta-analysis.
    Han L; Liu Y; Cao W; Yuan X; Li C
    Tumour Biol; 2013 Oct; 34(5):2545-50. PubMed ID: 23918309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MspI and Ile462Val polymorphisms in CYP1A1 and overall cancer risk: a meta-analysis.
    Wu B; Liu K; Huang H; Yuan J; Yuan W; Wang S; Chen T; Zhao H; Yin C
    PLoS One; 2013; 8(12):e85166. PubMed ID: 24391993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis.
    Hung RJ; Boffetta P; Brockmöller J; Butkiewicz D; Cascorbi I; Clapper ML; Garte S; Haugen A; Hirvonen A; Anttila S; Kalina I; Le Marchand L; London SJ; Rannug A; Romkes M; Salagovic J; Schoket B; Gaspari L; Taioli E
    Carcinogenesis; 2003 May; 24(5):875-82. PubMed ID: 12771031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP1A1 exon7 polymorphism is associated with lung cancer risk among the female population and among smokers: a meta-analysis.
    Xu CH; Wang Q; Qian Q; Zhan P; Yu LK
    Tumour Biol; 2013 Dec; 34(6):3901-11. PubMed ID: 23832578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined effects of CYP1A1 MspI and GSTM1 genetic polymorphisms on risk of lung cancer: an updated meta-analysis.
    Li W; Song LQ; Tan J
    Tumour Biol; 2014 Sep; 35(9):9281-90. PubMed ID: 24938875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP1A1 MspI polymorphisms and lung cancer risk: an updated meta-analysis involving 20,209 subjects.
    Ji YN; Wang Q; Lin XQ; Suo LJ
    Cytokine; 2012 Aug; 59(2):324-34. PubMed ID: 22579698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cytochrome P4501A1 gene polymorphisms and endometriosis: a meta-analysis.
    Fan W; Huang Z; Xiao Z; Li S; Ma Q
    J Assist Reprod Genet; 2016 Oct; 33(10):1373-1383. PubMed ID: 27525656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assessment of the associations between CYP1A1 polymorphisms and gastric cancer risk.
    Guo R; Guo X
    Tumour Biol; 2012 Aug; 33(4):1125-32. PubMed ID: 22359202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP1A1 MspI polymorphism and susceptibility to lung cancer in the Chinese population: an updated meta-analysis and review.
    Wang X; Yue K; Hao LR
    Int J Clin Exp Med; 2015; 8(8):11905-12. PubMed ID: 26550103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.